

The first non-surgical treatment for cellulite, QWO® is the first and only FDA-approved injectable for the treatment of moderate to severe cellulite in the buttocks of adult women. Together, there are three things that cause cellulite’s signature dimples: over time, skin thins, fat cells enlarge and push against the skin, and the fibrous bands under the skin’s surface thicken and cause tension. QWO was studied on all skin types and ethnicities.
QWO is made from enzymes called collagenases. These enzymes are thought to target the structural causes under the skin, where cellulite starts. It’s thought that QWO works by releasing fibrous bands, redistributing fat cells, and stimulating the growth of new collagen.
Endo Aesthetics conducted the largest clinical trials in the history of cellulite investigation to help determine the safety and efficacy of QWO.
These two identical trials enrolled 845 women in the United States, aged 18 or older, with moderate to severe cellulite in the buttocks. Reductions in cellulite severity were observed more frequently in the QWO group compared to the placebo group as measured by the investigator and patient cellulite severity scales.
Injections take about 10 minutes or less in the office. For best results, expect three treatment visits over the course of two months.
All Rights Reserved. Web Design & Internet Marketing by Studio III
The health and safety of our patients and staff is our top priority. Our in-office safety policies are aligned with the latest guidelines issued by the CDC and local government officials related to COVID-19.
New safety policies for patients:
New safety policies for office & staff: